Proteomic and transcriptomic analysis of LSC from patients with CML revealed c-Myc and p53 as master regulators of a set of transcripts/proteins that were found altered in these samples. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.